EKF Diagnostics Holdings Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0031509804
GBP
0.25
0.01 (4.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 11.66%

  • The company has been able to generate a Return on Equity (avg) of 11.66% signifying low profitability per unit of shareholders funds
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 10.04

 
3

Positive results in Dec 24

4

With ROE of 9.53%, it has a fair valuation with a 1.89 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 106 Million (Small Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.23

stock-summary
Return on Equity

9.53%

stock-summary
Price to Book

1.48

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.63%
0%
-21.63%
6 Months
-2.34%
0%
-2.34%
1 Year
-2.15%
0%
-2.15%
2 Years
-11.03%
0%
-11.03%
3 Years
-44.44%
0%
-44.44%
4 Years
-66.89%
0%
-66.89%
5 Years
-58.28%
0%
-58.28%

EKF Diagnostics Holdings Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.16%
EBIT Growth (5y)
-5.55%
EBIT to Interest (avg)
10.04
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.82
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.35%
ROE (avg)
11.66%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.89
EV to EBIT
17.27
EV to EBITDA
10.43
EV to Capital Employed
2.16
EV to Sales
2.37
PEG Ratio
11.11
Dividend Yield
NA
ROCE (Latest)
12.48%
ROE (Latest)
9.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by EKF Diagnostics Holdings Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -21.02% vs -18.58% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 128.12% vs -159.26% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.60",
          "val2": "66.60",
          "chgp": "-21.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.20",
          "val2": "14.20",
          "chgp": "-28.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-17.50",
          "chgp": "84.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.70",
          "val2": "-9.60",
          "chgp": "128.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.30%",
          "val2": "113.50%",
          "chgp": "-2.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
52.60
66.60
-21.02%
Operating Profit (PBDIT) excl Other Income
10.20
14.20
-28.17%
Interest
0.10
0.10
Exceptional Items
-2.80
-17.50
84.00%
Consolidate Net Profit
2.70
-9.60
128.12%
Operating Profit Margin (Excl OI)
90.30%
113.50%
-2.32%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -21.02% vs -18.58% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 128.12% vs -159.26% in Dec 2022

stock-summaryCompany CV
About EKF Diagnostics Holdings Plc stock-summary
stock-summary
EKF Diagnostics Holdings Plc
Pharmaceuticals & Biotechnology
EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.
Company Coordinates stock-summary
Company Details
Avon HSE, 19 Stanwell Road , PENARTH None : CF64 2EZ
Registrar Details